Evidence map›Paper›PMID 29249958›Full record

ArticleFrontiers in aging neuroscience2017

Unlocking Neurocognitive Substrates of Late-Life Affective Symptoms Using the Research Domain Criteria: Worry Is an Essential Dimension.

Sherry A Beaudreau, Nathan C Hantke, Nehjla Mashal, Christine E Gould, Victor W Henderson, Ruth O'Hara

Abstract read
In one paragraph

Article in Frontiers in aging neuroscience, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Effect of Worry Level on Recall Memory for Odors in ApoE-ε4 Carriers and Non-Carriers.Journal of the International Neuropsychological Society : JINS · 2019
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Sherry A BeaudreauDepartment of Psychiatry and Behavioral Sciences, Stanford University School of Medicine, Stanford, CA, United States.
Nathan C HantkeDepartment of Psychiatry and Behavioral Sciences, Stanford University School of Medicine, Stanford, CA, United States.
Nehjla MashalDepartment of Psychiatry and Behavioral Sciences, Stanford University School of Medicine, Stanford, CA, United States.
Christine E GouldDepartment of Psychiatry and Behavioral Sciences, Stanford University School of Medicine, Stanford, CA, United States.
Victor W HendersonDepartment of Health Research and Policy (Epidemiology), Stanford University School of Medicine, Stanford, CA, United States.
Ruth O'HaraDepartment of Psychiatry and Behavioral Sciences, Stanford University School of Medicine, Stanford, CA, United States.

Funding

Working Memory in Parkinson Disease: A Cognitive & Systems Neuroscience ApproachP50AG047366 · NIA · STANFORD UNIVERSITY · PI HENDERSON, VICTOR · 2015 to 2019
$7.9M
Neurocircuitry of Emotion: Distinguishing Late Life Anxiety and DepressionR01MH091342 · NIMH · STANFORD UNIVERSITY · PI ETKIN, AMIT, O'HARA, RUTH M · 2011 to 2015
$2.0M
Reducing Anxiety and Improving Functioning in Older VeteransIK2RX001478 · VA · VETERANS ADMIN PALO ALTO HEALTH CARE SYS · PI GOULD, CHRISTINE E. · 2015 to 2020
–
NIA NIH HHS P50 AG047366NIMH NIH HHS R01 MH091342RRD VA IK2 RX001478
6 · The paper itself

Abstract

While investigations have sought to identify the distinct and shared contributions of anxiety and depression to neurocognitive processes in late life, less is known regarding the further contribution of worry, a unique and critical dimension of affective dysregulation. Capturing the full range of symptoms, as inspired by the NIH Research Domain Criteria (RDoC), may provide finer-grained information on inter-relationships among worry, anxiety and depression on neurocognitive processing in later life. The objective of this study was to determine if the dimensional trait of worry intensifies known negative associations of dimensional measures of anxiety and depressive symptoms with neurocognitive processes, specifically cognitive control and memory processes. Using a cross-sectional and observational design, this study was conducted within a translational research center located with a Veterans medical center in Northern California. One hundred and nineteen community-residing older adults ages 65-91 years participated, and were characterized with psychiatric and neurocognitive dimensional measures. Affective symptom severity was assessed with the Penn State Worry Questionnaire, the Beck Anxiety Inventory (BAI), and the Beck Depression Inventory-II. Primary neurocognitive outcomes were inhibitory control assessed using a Stroop paradigm and delayed verbal memory assessed with the Rey Auditory Verbal Learning Test. Secondary outcomes included other less frequently examined cognitive control mechanisms (working memory, information processing, and verbal fluency) and memory processes (visual delayed memory). Contrary to prediction, the dimensional trait of worry attenuated negative associations between anxiety and depressive symptoms and inhibitory control on the one hand, and between depressive symptoms and delayed verbal memory processes on the other. In the secondary models, symptom dimensions were not associated with other cognitive control or visual delayed memory processes. Our fine-grained approach, in line with the NIMH RDoC model, suggests the neurocognitive processes associated with dimensional measures of late-life affective symptoms are dissociable. Specifically, dimensional measures of worry operate independently from other anxiety and depression symptoms to reveal differential patterns of neurocognitive processes associated with affective dysregulation.

Indexed as

anxietycognitioncognitive controldepressionolder adultsworry

Identifiers

PMID29249958
PMCPMC5715397

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.